Loading
HKSEHealthcareMedical - Pharmaceuticals
Latest quote
HK$0.825
−HK$0.025 · -2.94%
Regent Pacific Group Limited is an investment holding company that primarily focuses on the healthcare and life sciences sectors. The company is involved in the research, development, and sale of pharmaceutical products, with a notable focus on treatments for urological disorders. It also invests in a portfolio of both listed and unlisted corporate entities.
Latest quote
HK$0.825
−HK$0.025 · -2.94%
Regent Pacific Group Limited is an investment holding company that primarily focuses on the healthcare and life sciences sectors. The company is involved in the research, development, and sale of pharmaceutical products, with a notable focus on treatments for urological disorders. It also invests in a portfolio of both listed and unlisted corporate entities.
52-week range
Current HK$0.825
Historical prices · Market data may be delayed.
Regent Pacific Group Limited is an investment holding company that primarily focuses on the healthcare and life sciences sectors. The company is involved in the research, development, and sale of pharmaceutical products, with a notable focus on treatments for urological disorders. It also invests in a portfolio of both listed and unlisted corporate entities.
52-week range
Current HK$0.825
Reported history and fiscal-year consensus
Reported history and fiscal-year consensus
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Jun 5, 2023 | 1:20 | — | — |
Stock split | Jun 10, 2016 | 1:10 | — | — |
Stock split | Nov 23, 2005 | 2,437:1,000 | — | — |
Effective Jun 5, 2023
1:20
Effective Jun 10, 2016
1:10
Effective Nov 23, 2005
2,437:1,000
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
